Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction

Biophysical Chemistry

Volumn 158, Issue 1, 2011, Pages 81-89

  Martin, Douglas J ^a   Ramirez Alvarado, Marina ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

Amyloid; Binding; Kinetics; Light chain amyloidosis; Mechanism

Indexed keywords

AMYLOID; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN;

AMYLOIDOSIS; ARTICLE; ELECTROSTIMULATION; IN VITRO STUDY; KINETICS; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING;

AMYLOID; GLYCOSAMINOGLYCANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN LIGHT CHAINS; KINETICS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; STATIC ELECTRICITY;

EID: 79960193042     PISSN: 03014622     EISSN: 18734200     Source Type: Journal    
DOI: 10.1016/j.bpc.2011.05.011     Document Type: Article

References (44)

1. X. Wang, N.D. Hammer, and M.R. Chapman The molecular basis of functional bacterial amyloid polymerization and nucleation J. Biol. Chem. 283 2008 21530 21539
2. R. Wickner, H. Edskes, F. Shewmaker, and T. Nakayashiki Prions of fungi: inherited structures and biological roles Nat. Rev. Microbiol. 5 2007 611 618 (Pubitemid 47074116)
3. J. Tyedmers, M.L. Madariaga, and S. Lindquist Prion switching in response to environmental stress PLoS Biol. 6 2008 e294
4. S. Maji, M. Perrin, M. Sawaya, S. Jessberger, K. Vadodaria, R. Rissman, P. Singru, K. Nilsson, R. Simon, D. Schubert, D. Eisenberg, J. Rivier, P. Sawchenko, W. Vale, and R. Riek Functional amyloids as natural storage of peptide hormones in pituitary secretory granules Science 325 2009 328 332
5. D. Hamada, I. Yanagihara, and K. Tsumoto Engineering amyloidogenicity towards the development of nanofibrillar materials Trends Biotechnol. 22 2004 93 97 (Pubitemid 38130177)
6. J.H. Magnus, T. Stenstad, S.O. Kolset, and G. Husby Glycosaminoglycans in extracts of cardiac amyloid fibrils from familial amyloid cardiomyopathy of Danish origin related to variant transthyretin Met 111 Scand. J. Immunol. 34 1991 63 69
7. H. Ohishi, M. Skinner, N. Sato-Araki, T. Okuyama, F. Gejyo, A. Kimura, A.S. Cohen, and K. Schmid Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen Clin. Chem. 36 1990 88 91
8. A. Alexandrescu Amyloid accomplices and enforcers Protein Sci. 14 2004 1 12 (Pubitemid 40054111)
9. A.D. Snow, and R. Kisilevsky Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis A histochemical study, Lab Invest 53 1985 37 44 (Pubitemid 15237710)
10. S.J. Pollack, Sadler II, S.R. Hawtin, V.J. Tailor, and M.S. Shearman Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells Neurosci. Lett. 184 1995 113 116
11. N.M. Timmer, T.J. Schirris, I.B. Bruinsma, I. Otte-Holler, T.H. van Kuppevelt, R.M. de Waal, and M.M. Verbeek Aggregation and cytotoxic properties towards cultured cerebrovascular cells of Dutch-mutated Abeta40 (DAbeta(1-40)) are modulated by sulfate moieties of heparin Neurosci. Res. 66 2010 380 389
12. J.J. Valle-Delgado, M. Alfonso-Prieto, N.S. de Groot, S. Ventura, J. Samitier, C. Rovira, and X. Fernandez-Busquets Modulation of A{beta}42 fibrillogenesis by glycosaminoglycan structure FASEB J 404 2010 337052
13. A.G. Woods, D.H. Cribbs, E.R. Whittemore, and C.W. Cotman Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate beta-amyloid(25-35) induced neurodegeneration in cultured hippocampal neurons Brain Res. 697 1995 53 62
14. R.W. McLaughlin, J.K. De Stigter, L.A. Sikkink, E.M. Baden, and M. Ramirez-Alvarado The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein Protein Sci. 15 2006 1710 1722
15. J.Y. Suk, F. Zhang, W.E. Balch, R.J. Linhardt, and J.W. Kelly Heparin accelerates gelsolin amyloidogenesis Biochemistry 45 2006 2234 2242 (Pubitemid 43271322)
16. J.A. Cohlberg, J. Li, V.N. Uversky, and A.L. Fink Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro Biochemistry 41 2002 1502 1511 (Pubitemid 34112739)
17. N. Motamedi-Shad, E. Monsellier, S. Torrassa, A. Relini, and F. Chiti Kinetic analysis of amyloid formation in the presence of heparan sulfate. Faster unfolding and change of pathway J. Biol. Chem. 284 2009 1 24
18. A. Borysik, I. Morten, S. Radford, and E. Hewitt Specific glycosaminoglycans promote unseeded amyloid formation from β2-microglobulin under physiological conditions Kidney Int. 72 2007 174 181 (Pubitemid 47067386)
19. A. Relini, S. De Stefano, S. Torrassa, O. Cavalleri, R. Rolandi, A. Gliozzi, S. Giorgetti, S. Raimondi, L. Marchese, L. Verga, A. Rossi, M. Stoppini, and V. Bellotti Heparin strongly enhances the formation of β2-Microglobulin amyloid fibrils in the presence of type I collagen J. Biol. Chem. 283 2007 4912 4920
20. S. Yamamoto, I. Yamaguchi, K. Hasegawa, S. Tsutsumi, Y. Goto, F. Gejyo, and H. Naiki Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH J. Am. Soc. Nephrol. 15 2004 126 133 (Pubitemid 38020704)
21. R. Ren, Z. Hong, H. Gong, K. Laporte, M. Skinner, D.C. Seldin, C.E. Costello, L.H. Connors, and V. Trinkaus-Randall The role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils J. Biol. Chem. 285 2010 37672 37682
22. J.R. Bishop, M. Schuksz, and J.D. Esko Heparan sulphate proteoglycans fine-tune mammalian physiology Nature 446 2007 1030 1037 (Pubitemid 46676065)
23. A. Varki Nothing in glycobiology makes sense, except in the light of evolution Cell 126 2006 841 845 (Pubitemid 44310787)
24. X. Shi, and J. Zaia Organ-specific heparan sulfate structural phenotypes J. Biol. Chem. 284 2009 11806 11814
25. M. Calamai, J.R. Kumita, J. Mifsud, C. Parrini, M. Ramazzotti, G. Ramponi, N. Taddei, F. Chiti, and C.M. Dobson Nature and significance of the interactions between amyloid fibrils and biological polyelectrolytes Biochemistry 45 2006 12806 12815 (Pubitemid 44630867)
26. M.P. Gomes, Y. Cordeiro, and J.L. Silva The peculiar interaction between mammalian prion protein and RNA Prion 2 2008 64 66
27. E.M. Baden, L.A. Sikkink, and M. Ramirez-Alvarado light chain amyloidosis - current findings and future prospects Curr. Protein Pept. Sci. 10 2009 500 508
28. D.J. Martin, and M. Ramirez-Alvarado Comparison of amyloid fibril formation by two closely related immunoglobulin light chain variable domains Amyloid 17 2010 129 136
29. E.G. Randles, J.R. Thompson, D.J. Martin, and M. Ramirez-Alvarado Structural alterations within native amyloidogenic immunoglobulin light chains J. Mol. Biol. 389 2009 199 210
30. E.M. Baden, B.A. Owen, F.C. Peterson, B.F. Volkman, M. Ramirez-Alvarado, and J.R. Thompson Altered dimer interface decreases stability in an amyloidogenic protein J. Biol. Chem. 283 2008 15853 15860
31. R. Wetzel Kinetics and thermodynamics of amyloid fibril assembly Acc. Chem. Res. 39 2006 671 679
32. Z. Qin, D. Hu, M. Zhu, and A.L. Fink Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation Biochemistry 46 2007 3521 3531 (Pubitemid 46449169)
33. L.A. Sikkink, and M. Ramirez-Alvarado Salts enhance both protein stability and amyloid formation of an immunoglobulin light chain Biophys. Chem. 135 2008 25 31
34. N. Motamedi-Shad, E. Monsellier, and F. Chiti Amyloid formation by the model protein muscle acylphosphatase is accelerated by heparin and heparan sulphate through a scaffolding-based mechanism J. Biochem. 146 2009 805 814
35. J.B. Ancsin, and R. Kisilevsky The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis J. Biol. Chem. 274 1999 7172 7181
36. D.M. Hartley, D.M. Walsh, C.P. Ye, T. Diehl, S. Vasquez, P.M. Vassilev, D.B. Teplow, and D.J. Selkoe Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons J. Neurosci. 19 1999 8876 8884 (Pubitemid 30226709)
37. E. Elimova, R. Kisilevsky, W.A. Szarek, and J.B. Ancsin Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy FASEB J. 18 2004 1749 1751 (Pubitemid 39561672)
38. C.R. Bodner, A.S. Maltsev, C.M. Dobson, and A. Bax Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy Biochemistry 49 2010 862 871
39. D. Hatters Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II J. Biol. Chem. 277 2002 7824 7830 (Pubitemid 34968230)
40. A. Minton Models for excluded volume interaction between an unfolded protein and rigid macromolecular cosolutes: macromolecular crowding and protein stability revisited Biophys. J. 88 2004 971 985 (Pubitemid 40975932)
41. L.A. Munishkina, E.M. Cooper, V.N. Uversky, and A.L. Fink The effect of macromolecular crowding on protein aggregation and amyloid fibril formation J. Mol. Recognit. 17 2004 456 464 (Pubitemid 39218989)
42. M.G. Cacace, E.M. Landau, and J.J. Ramsden The Hofmeister series: salt and solvent effects on interfacial phenomena Q. Rev. Biophys. 30 1997 241 277 (Pubitemid 27491348)
43. J.M. Broering, and A.S. Bommarius Evaluation of Hofmeister effects on the kinetic stability of proteins J. Phys. Chem. B 109 2005 20612 20619 (Pubitemid 41609792)
44. M.G. Zagorski, J. Yang, H. Shao, K. Ma, H. Zeng, and A. Hong Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity Methods Enzymol. 309 1999 189 204 (Pubitemid 29446450)